Education
About Us
Working with TipRanks
Follow Us
Sun Pharma Advanced Research Co. Ltd. (IN:SPARC)
:SPARC
SPARC Stock Chart & Stats
₹136.30
-₹2.58(-1.32%)
At close: 4:00 PM EST
₹136.30
-₹2.58(-1.32%)
Day’s Range― - ―
52-Week Range₹109.20 - ₹234.25
Previous CloseN/A
Volume383.41K
Average Volume (3M)24.00K
Market Cap
₹43.10B
Enterprise Value₹50.70B
Total Cash (Recent Filing)₹19.64M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)―
Beta1.61
Next Earnings
Jan 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.34
Shares Outstanding324,521,580
10 Day Avg. Volume27,089
30 Day Avg. Volume24,005
Financial Highlights & Ratios
PEG Ratio1.20
Price to Book (P/B)-21.89
Price to Sales (P/S)66.17
P/FCF Ratio-12.81
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Sun Pharma Advanced Research Co. Ltd. News
SPARC FAQ
What was Sun Pharma Advanced Research Co. Ltd.’s price range in the past 12 months?
Sun Pharma Advanced Research Co. Ltd. lowest stock price was ₹109.20 and its highest was ₹234.25 in the past 12 months.
What is Sun Pharma Advanced Research Co. Ltd.’s market cap?
Sun Pharma Advanced Research Co. Ltd.’s market cap is ₹43.10B.
When is Sun Pharma Advanced Research Co. Ltd.’s upcoming earnings report date?
Sun Pharma Advanced Research Co. Ltd.’s upcoming earnings report date is Jan 30, 2026 which is in 43 days.
How were Sun Pharma Advanced Research Co. Ltd.’s earnings last quarter?
Sun Pharma Advanced Research Co. Ltd. released its earnings results on Nov 10, 2025. The company reported -₹2.337 earnings per share for the quarter, missing the consensus estimate of N/A by -₹2.337.
Is Sun Pharma Advanced Research Co. Ltd. overvalued?
According to Wall Street analysts Sun Pharma Advanced Research Co. Ltd.’s price is currently Overvalued.
Does Sun Pharma Advanced Research Co. Ltd. pay dividends?
Sun Pharma Advanced Research Co. Ltd. does not currently pay dividends.
What is Sun Pharma Advanced Research Co. Ltd.’s EPS estimate?
Sun Pharma Advanced Research Co. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sun Pharma Advanced Research Co. Ltd. have?
Sun Pharma Advanced Research Co. Ltd. has 324,521,580 shares outstanding.
What happened to Sun Pharma Advanced Research Co. Ltd.’s price movement after its last earnings report?
Sun Pharma Advanced Research Co. Ltd. reported an EPS of -₹2.337 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.388%.
Which hedge fund is a major shareholder of Sun Pharma Advanced Research Co. Ltd.?
Currently, no hedge funds are holding shares in IN:SPARC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sun Pharma Advanced Research Co. Ltd.
Sun Pharma Advanced Research Company Ltd. (SPARC) is a leading research-driven pharmaceutical company based in India, specializing in the development of differentiated formulations, complex generics, and novel drug delivery systems. A subsidiary of Sun Pharmaceutical Industries Ltd., SPARC focuses on innovative research that supports the development of new therapies and enhances the existing product portfolio, primarily in therapeutic areas such as oncology, neurology, and dermatology. The company leverages advanced research capabilities and state-of-the-art technology to bring high-quality products to market.
Technical Analysis
Aarti Drugs Limited
―
RPG Life Sciences Limited
―
Supriya Lifescience Limited
―
Suven Life Sciences Limited
―
Thyrocare Technologies Ltd
―